Interpace Biosciences Inc (IDXG)
3.09
-0.19
(-5.79%)
USD |
OTCM |
Nov 14, 15:46
Interpace Biosciences Shareholders Equity (Quarterly): -59.03M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -59.03M |
March 31, 2024 | -61.14M |
December 31, 2023 | -61.67M |
September 30, 2023 | -62.68M |
June 30, 2023 | -62.21M |
March 31, 2023 | -62.54M |
December 31, 2022 | -63.07M |
September 30, 2022 | -61.59M |
June 30, 2022 | -47.95M |
March 31, 2022 | -44.34M |
December 31, 2021 | -42.42M |
September 30, 2021 | -38.65M |
June 30, 2021 | -35.79M |
March 31, 2021 | -32.90M |
December 31, 2020 | -29.08M |
September 30, 2020 | -21.80M |
June 30, 2020 | 1.693M |
March 31, 2020 | 6.838M |
December 31, 2019 | 21.69M |
September 30, 2019 | 23.60M |
June 30, 2019 | 30.83M |
March 31, 2019 | 35.77M |
December 31, 2018 | 15.45M |
September 30, 2018 | 36.03M |
June 30, 2018 | 38.55M |
Date | Value |
---|---|
March 31, 2018 | 39.76M |
December 31, 2017 | 39.87M |
September 30, 2017 | 36.38M |
June 30, 2017 | 36.34M |
March 31, 2017 | 24.57M |
December 31, 2016 | 6.531M |
September 30, 2016 | -1.479M |
June 30, 2016 | 5.993M |
March 31, 2016 | 8.306M |
December 31, 2015 | 13.04M |
September 30, 2015 | 5.861M |
June 30, 2015 | 10.30M |
March 31, 2015 | 16.62M |
December 31, 2014 | 20.12M |
September 30, 2014 | 25.42M |
June 30, 2014 | 29.35M |
March 31, 2014 | 31.34M |
December 31, 2013 | 32.48M |
September 30, 2013 | 36.01M |
June 30, 2013 | 37.72M |
March 31, 2013 | 37.88M |
December 31, 2012 | 35.63M |
September 30, 2012 | 59.18M |
June 30, 2012 | 59.74M |
March 31, 2012 | 59.57M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-63.07M
Minimum
Dec 2022
21.69M
Maximum
Dec 2019
-39.82M
Average
-44.34M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
Fonar Corp | 165.97M |
XWELL Inc | 8.798M |
ProPhase Labs Inc | 44.08M |
Applied DNA Sciences Inc | 12.39M |
Veracyte Inc | 1.176B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 12.97M |
Total Liabilities (Quarterly) | 72.00M |
Debt to Equity Ratio | -0.1149 |
Current Ratio | 0.5342 |
Net Debt Paydown Yield | 26.02% |